FTO rs35420030: Genetic Associations with BMI and Obesity
The rs35420030 variant is a genetic marker located near the FTO gene. It has been identified in studies investigating the genetic architecture of body mass index (BMI) and obesity through non-additive genetic modeling.
What each genotype means
Typical BMI association
This genotype is associated with body mass index (BMI) traits as identified through non-additive genetic modeling near the FTO gene. Research suggests that variations in this region influence metabolic traits primarily through their effect on BMI. As these associations are statistical, they do not account for individual lifestyle factors or other genetic influences on weight.
This genotype is observed at low frequencies in most populations.
Intermediate BMI association
Individuals with this genotype show an intermediate association with BMI-related traits compared to other genotypes at this locus. The FTO gene region is well-studied for its role in weight-related traits, though the specific impact of this variant is considered moderate. Please remember that BMI is influenced by a complex interplay of genetics, environment, and personal habits.
This genotype is observed at low frequencies in most populations.
Typical BMI association
This genotype is associated with BMI-related traits in the FTO gene region. Current research indicates that the influence of FTO variants on metabolic health is largely mediated by their effect on body mass index. These findings are based on population-level data and should be viewed as one of many factors contributing to your overall health profile.
This genotype is observed at low frequencies in most populations.
Understanding the rs35420030 Variant
The rs35420030 variant is a single nucleotide polymorphism (SNP) situated in the genomic region associated with the FTO gene. In the context of genetic research, SNPs are used as markers to identify regions of the genome that may contribute to complex traits. This specific variant has gained attention in scientific literature for its role in studies that move beyond traditional additive genetic models. While many genetic variants are studied for their per-allele effect—where each copy of an allele adds a certain amount of risk—rs35420030 has been examined for potential non-additive effects. This means researchers are looking at whether the presence of one or two copies of the variant might influence BMI in ways that are not simply a linear accumulation of risk, providing a more nuanced view of how genetics influences body weight.
The Role of the FTO Gene
The FTO gene, often referred to as the 'fat mass and obesity-associated' gene, is one of the most well-studied loci in human obesity research. It is highly expressed in the brain and is thought to play a role in energy balance and appetite regulation. Variations in and around the FTO gene have been consistently linked to differences in body mass index (BMI) and the risk of obesity across various populations. By influencing how the body regulates energy intake and expenditure, the FTO gene acts as a significant contributor to the complex interplay between genetics and environment. Research into variants like rs35420030 helps scientists map the regulatory landscape of this gene, aiming to understand how specific DNA changes might alter the expression of FTO and subsequently impact metabolic health.
Research and Statistical Significance
Research into rs35420030 often involves large-scale genome-wide association studies (GWAS). These studies analyze the DNA of thousands of individuals to find correlations between specific genetic markers and traits like BMI. The evidence for FTO variants is generally considered moderate to strong in terms of statistical association, though the effect size of any single variant is typically small. Studies utilizing non-additive modeling have sought to determine if certain genotypes show a 'recessive' or 'dominant' pattern of influence on BMI. While most genetic effects on BMI are additive, identifying exceptions like those potentially linked to FTO variants helps refine our understanding of genetic architecture. It is important to remember that these associations are based on population averages and do not predict the BMI of any specific individual, as lifestyle and environmental factors remain dominant.
Interpreting Genetic Information
The rs35420030 variant is noted as having a low frequency in many populations. When interpreting genetic data, it is crucial to distinguish between a statistical association and a medical cause. Having a particular genotype at this locus does not mean an individual will necessarily have a high or low BMI. Obesity is a multifactorial condition influenced by diet, physical activity, socioeconomic factors, and a vast array of genetic variants. Readers should view this information as an educational insight into the complexity of human genetics rather than a tool for personal health assessment. If you have concerns about your weight or metabolic health, the most effective approach is to consult with a healthcare professional. They can provide a comprehensive evaluation that considers your unique clinical profile, rather than relying on isolated genetic markers.
How common is this variant?
The rs35420030 variant is reported to have a low frequency across most studied populations, which is a common characteristic for many variants identified in GWAS.
Frequently asked questions
Does this variant mean I am genetically predisposed to obesity?
Genetic variants like rs35420030 are associated with small changes in BMI at a population level. They do not determine your weight, which is heavily influenced by lifestyle and environment.
Can I use this SNP to predict my future BMI?
No. Genetic markers are not predictive tools for individual health outcomes. BMI is a complex trait influenced by many factors beyond a single genetic variant.
What is the difference between additive and non-additive effects?
An additive effect means each copy of an allele increases risk by a set amount. Non-additive effects, like recessive or dominant patterns, mean the risk does not increase in a simple linear way.
Should I get tested for this variant?
There is no clinical utility in testing for this specific variant for weight management. If you have health concerns, consult a doctor for a professional assessment.
Sources & further reading
Educational information only, last refreshed 11/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs35420030?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FTO
This variant is strongly associated with increased body mass index and obesity risk.
Variant in FTO associated with body mass index and obesity-related traits; evidence for sleep apnea is indirect via BMI.
Intronic regulatory variant in the FTO/IRX3 cluster strongly linked to elevated BMI, obesity susceptibility, and metabolic dysregulation.
Intronic SNP conferring a distinct preference for morning chronotype ('early bird' vs 'night owl') independently of metabolic phenotypes.
Intronic variant within the FTO locus, showing replicated association with body mass index and obesity risk.
Commonly associated with body mass index (BMI) and obesity risk, though sometimes misattributed in consumer genomics to facial morphology.